Catheter-directed thrombolysis in COVID-19 pneumonia with acute PE: Thinking beyond the guidelines

Thromb Res. 2020 Aug:192:9-11. doi: 10.1016/j.thromres.2020.05.007. Epub 2020 May 8.

Authors

S D Qanadli¹, L Gudmundsson², D C Rotzinger²

Affiliations

¹ Cardiothoracic and Vascular Division, Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland. Electronic address: salah.qanadli@chuv.ch.
² Cardiothoracic and Vascular Division, Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, 1011 Lausanne, Switzerland.

Abstract

•
Patients having COVID-19 pneumonia are at risk of venous thromboembolism.
•
Prophylaxis versus anticoagulation for severely ill patients is currently debated.
•
No specific guidelines for the management of severe pulmonary embolism exist.
•
Endovascular pulmonary embolism therapy may play a critical role in severe COVID-19.

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections
Fibrinolytic Agents
Humans
Pandemics
Pneumonia*
Pneumonia, Viral
SARS-CoV-2
Thrombolytic Therapy*

Substances

Fibrinolytic Agents